2020 Vision. Anteo Tech, Share price 6th Dec 2020., page-22

Leviathin, ADO is a different company with a different Board of Directors with a well planed strategy for POC and high end performance Battery technologies, it looks like Management are delivering on multiple fronts conservatively to me, the market is always slow to catch on.

The Company strategy is to leverage its core IP in being a supplier of superior surface modifying specialty products and services focused on the Battery and Life Science diagnostics markets (which includes point of care testing and in vitro diagnostics in the life science sectors).

The strategy for each of the chosen focus areas is:

Energy Division
• Targeting world leading partners to develop initially collaborations to accelerate and validate the potential of AnteoCoatTM in improving silicon content, integration energy density and improve cycle efficiency in Lithium-ion batteries.

• Convert the chosen collaborations into commercial development partnerships leading ultimately to realise the use of AnteoCoatTM in the lithium ion anode battery manufacturing process and the licensing of Anteo’s IP for the use of high Silicon content composites in high capacity anodes.

Life Science Division

• Target the rapidly expanding market of quantitative lateral flow point of care diagnostics where the superior conjugation performance of AnteoBindTM can potentially solve difficult assay development problems encountered with the use of Europium, Gold, Quantum Dots, Dyes and potentially Carbon, through:

- Expanding commercial partnerships to extend the reach of AnteoBindTM to Point of Care Test (POCT) developers.

- Continue to demonstrate the application potential and build from that a service offering to support technical evaluation stage and initial product development for POC test developers. In the medical technology sector where the Company’s AnteoReleaseTM has future potential,
the Company has protected its Intellectual Property but slowed development internally in this area given the typical long lead times to realise value